Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
The primary objective of the study is to investigate neuroregenerative efficacy (proof of concept) of intrathecal treatment with autologous MSCs as measured by neurophysiological parameters in patients with progressive MS. Secondary objectives are to assess neuroregenerative efficacy as measured by other neurophysiological parameters as well as clinical, opthalmological and MRI modalities, and to assess safety of the treatment procedure.
Epistemonikos ID: 2e8e99b06d12c0441ba6cb91dcbf3f3df5f381c3
First added on: Mar 31, 2022